By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Immunotech Biopharm Ltd

Immunotech Biopharm Ltd (6978.HK)

HKSE Market Data in HKD, Fundamentals in CNY
$5.28
+$0.01
+0.19%
Last Update: 1 Sept 2025, 03:35
$2.72B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$1.50 - $6.15
52 Week Range

6978.HK Stock Price Chart

Explore Immunotech Biopharm Ltd interactive price chart. Choose custom timeframes to analyze 6978.HK price movements and trends.

6978.HK Company Profile

Discover essential business fundamentals and corporate details for Immunotech Biopharm Ltd (6978.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

10 Jul 2020

Employees

154.00

CEO

Yu Wang

Description

Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. Its core product is EAL, a multi-target cellular immunotherapy product that is in Phase II clinical trials for the prevention of postsurgical recurrence of liver cancer. The company is also conducting pre-clinical and clinical trial studies for EAL to treat lung cancer, glioma, gastric cancer, and colorectal cancer. In addition, it develops 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; CAR-T-19 injection product for B-cell acute lymphoblastic leukaemia; and TCR-T cell series products to treat solid tumors. The company was founded in 2006 and is headquartered in Beijing, the People's Republic of China.

6978.HK Financial Timeline

Browse a chronological timeline of Immunotech Biopharm Ltd corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 31 Mar 2025

EPS came in at -$0.20 .

Earnings released on 24 Aug 2024

EPS came in at -$0.00 .

Earnings released on 24 Aug 2024

EPS came in at -$0.19 .

Earnings released on 29 Mar 2024

EPS came in at -$0.47 .

Earnings released on 29 Mar 2024

EPS came in at -$0.00 .

Earnings released on 27 Aug 2023

EPS came in at -$0.00 .

Earnings released on 27 Aug 2023

EPS came in at -$0.25 .

Earnings released on 25 Mar 2023

EPS came in at -$0.00 .

Earnings released on 25 Mar 2023

EPS came in at -$0.39 .

Earnings released on 26 Aug 2022

EPS came in at -$0.32 .

Earnings released on 26 Aug 2022

EPS came in at -$0.00 .

Earnings released on 31 Dec 2021

EPS came in at -$0.49 .

Earnings released on 30 Sept 2021

EPS came in at -$0.00 .

Earnings released on 24 Aug 2021

EPS came in at -$0.00 .

Earnings released on 24 Aug 2021

EPS came in at -$0.34 .

Earnings released on 26 Mar 2021

EPS came in at -$0.62 .

Earnings released on 26 Mar 2021

EPS came in at -$0.00 .

Earnings released on 14 Sept 2020

EPS came in at -$0.50 .

6978.HK Stock Performance

Access detailed 6978.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run